Cargando…

Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand

Incidence and Malignancy Rates Classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year Tertiary Center experience in Thailand. BACKGROUND: Fine-needle aspiration (FNA) of the thyroid is considered the best diagnostic tool for preoperative evaluation of thyroid nodu...

Descripción completa

Detalles Bibliográficos
Autores principales: Thewjitcharoen, Yotsapon, Butadej, Siriwan, Nakasatien, Soontaree, Chotwanvirat, Phawinpon, Porramatikul, Sriurai, Krittiyawong, Sirinate, Lekpittaya, Nampetch, Himathongkam, Thep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378904/
https://www.ncbi.nlm.nih.gov/pubmed/30815363
http://dx.doi.org/10.1016/j.jcte.2018.12.004
_version_ 1783396013059342336
author Thewjitcharoen, Yotsapon
Butadej, Siriwan
Nakasatien, Soontaree
Chotwanvirat, Phawinpon
Porramatikul, Sriurai
Krittiyawong, Sirinate
Lekpittaya, Nampetch
Himathongkam, Thep
author_facet Thewjitcharoen, Yotsapon
Butadej, Siriwan
Nakasatien, Soontaree
Chotwanvirat, Phawinpon
Porramatikul, Sriurai
Krittiyawong, Sirinate
Lekpittaya, Nampetch
Himathongkam, Thep
author_sort Thewjitcharoen, Yotsapon
collection PubMed
description Incidence and Malignancy Rates Classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year Tertiary Center experience in Thailand. BACKGROUND: Fine-needle aspiration (FNA) of the thyroid is considered the best diagnostic tool for preoperative evaluation of thyroid nodules. The introduction of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) in 2010 provided the opportunity to establish worldwide standard for reporting and terminology guidelines for diagnostic categories. It is recommended that every institution evaluates the risk of malignancy (ROM) in each category for quality improvement process. AIM: To assess the effectiveness of TBSRTC method at our institution using cyto-histological correlation. METHOD: A retrospective 8-year (2010–2017) audit of thyroid FNA done by thyroid specialists at Theptarin hospital. The FNA results were classified according to TBSRTC. Histopathology reports for operated cases were used to correlate cytology and final histopathology. RESULTS: A total of 2735 thyroid FNA from 2115 patients (mean age 45.7 ± 13.1 years, female 89.8%) were examined. The rates of non-diagnostic, benign, atypia of undetermined significance (AUS), follicular neoplasm, suspected for malignancy, and malignant cases were 21.1%, 66.6%, 4.7%, 2.4%, 1.8%, and 3.3% respectively. There were 188 patients (9%) who underwent surgical resection with available histopathology. Malignancy rates in operated thyroid nodules were 20.0%, 4.2%, 9.4%, 23.5%, 57.1%, and 90.3% for categories 1 to 6, respectively. The sensitivity, specificity, negative predictive value, and positive predictive value were 96.6%, 88.5%, 95.8%, and 90.3, respectively. CONCLUSIONS: Preoperative diagnosis of thyroid nodules using TBSRTC in our hospital was comparable with other studies. The uniform diagnostic criteria of the Bethesda System help avoid misinterpretation while sharing local experience with international benchmarks.
format Online
Article
Text
id pubmed-6378904
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63789042019-02-27 Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand Thewjitcharoen, Yotsapon Butadej, Siriwan Nakasatien, Soontaree Chotwanvirat, Phawinpon Porramatikul, Sriurai Krittiyawong, Sirinate Lekpittaya, Nampetch Himathongkam, Thep J Clin Transl Endocrinol Research Paper Incidence and Malignancy Rates Classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year Tertiary Center experience in Thailand. BACKGROUND: Fine-needle aspiration (FNA) of the thyroid is considered the best diagnostic tool for preoperative evaluation of thyroid nodules. The introduction of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) in 2010 provided the opportunity to establish worldwide standard for reporting and terminology guidelines for diagnostic categories. It is recommended that every institution evaluates the risk of malignancy (ROM) in each category for quality improvement process. AIM: To assess the effectiveness of TBSRTC method at our institution using cyto-histological correlation. METHOD: A retrospective 8-year (2010–2017) audit of thyroid FNA done by thyroid specialists at Theptarin hospital. The FNA results were classified according to TBSRTC. Histopathology reports for operated cases were used to correlate cytology and final histopathology. RESULTS: A total of 2735 thyroid FNA from 2115 patients (mean age 45.7 ± 13.1 years, female 89.8%) were examined. The rates of non-diagnostic, benign, atypia of undetermined significance (AUS), follicular neoplasm, suspected for malignancy, and malignant cases were 21.1%, 66.6%, 4.7%, 2.4%, 1.8%, and 3.3% respectively. There were 188 patients (9%) who underwent surgical resection with available histopathology. Malignancy rates in operated thyroid nodules were 20.0%, 4.2%, 9.4%, 23.5%, 57.1%, and 90.3% for categories 1 to 6, respectively. The sensitivity, specificity, negative predictive value, and positive predictive value were 96.6%, 88.5%, 95.8%, and 90.3, respectively. CONCLUSIONS: Preoperative diagnosis of thyroid nodules using TBSRTC in our hospital was comparable with other studies. The uniform diagnostic criteria of the Bethesda System help avoid misinterpretation while sharing local experience with international benchmarks. Elsevier 2018-12-14 /pmc/articles/PMC6378904/ /pubmed/30815363 http://dx.doi.org/10.1016/j.jcte.2018.12.004 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Thewjitcharoen, Yotsapon
Butadej, Siriwan
Nakasatien, Soontaree
Chotwanvirat, Phawinpon
Porramatikul, Sriurai
Krittiyawong, Sirinate
Lekpittaya, Nampetch
Himathongkam, Thep
Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
title Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
title_full Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
title_fullStr Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
title_full_unstemmed Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
title_short Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
title_sort incidence and malignancy rates classified by the bethesda system for reporting thyroid cytopathology (tbsrtc) – an 8-year tertiary center experience in thailand
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378904/
https://www.ncbi.nlm.nih.gov/pubmed/30815363
http://dx.doi.org/10.1016/j.jcte.2018.12.004
work_keys_str_mv AT thewjitcharoenyotsapon incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT butadejsiriwan incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT nakasatiensoontaree incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT chotwanviratphawinpon incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT porramatikulsriurai incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT krittiyawongsirinate incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT lekpittayanampetch incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand
AT himathongkamthep incidenceandmalignancyratesclassifiedbythebethesdasystemforreportingthyroidcytopathologytbsrtcan8yeartertiarycenterexperienceinthailand